Purdue Pharma successfully resolves Hatch-Waxman patent infringement claims against Amneal and Kashiv related to OxyContin®
Clients Purdue Pharma L.P.
Jones Day successfully represented Purdue Pharma L.P. in related Hatch-Waxman patent infringement actions against defendants Amneal Pharmaceuticals, LLC and Kashiv Pharma, LLC, pertaining to the submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of OxyContin®, a widely prescribed treatment for pain relief. Purdue came to a successful resolution of the dispute through settlement.
Purdue Pharma L.P., et al. v. Amneal Pharmaceuticals, LLC, Case No. 1:15-cv-01152 (D. Del.)